NewGenIvf (NIVF) Debt to Equity (2024 - 2025)

NewGenIvf (NIVF) reported Debt to Equity of $0.02 for Q4 2025, up 135.82% year-over-year from $0.01 in Q4 2024, and down 41.33% quarter-over-quarter from $0.03 in Q2 2025.

NewGenIvf (NIVF) Debt to Equity (2024 - 2025) Analysis & Trends

NewGenIvf (NIVF) has 2 years of Debt to Equity data on file, last reported at $0.02 in Q4 2025.

  • Debt to Equity for Q4 2025 came in at $0.02, up 135.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.02 (up 135.82% YoY), and the FY2025 annual result was $0.02, up 135.82% from the prior year.
  • Debt to Equity declined to $0.02 in Q4 2025 per NIVF's latest filing, from $0.03 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.03 in Q2 2025 and troughed at -$0.05 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn -16.13
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn 2.74
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn -22.31
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn 0.78
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn 0.06
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn 0.63
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn 0.51
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn 0.11
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn 0.05
10 NewGenIvf - - 524,025.00 0.02

Historic Data

Download Data
DateValue
Dec 31, 2025 0.02
Jun 30, 2025 0.03
Dec 31, 2024 -0.05